Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
Jiewen Wang, Guangbo Kang, Haibin Yuan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Tau-targeting therapies for Alzheimer disease: current status and future directions
Erin E. Congdon, Changyi Ji, Amber M. Tetlow, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 715-736
Closed Access | Times Cited: 130
Nanobodies: Robust miniprotein binders in biomedicine
Jeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 195, pp. 114726-114726
Open Access | Times Cited: 44
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
Mehdi Arbabi‐Ghahroudi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5009-5009
Open Access | Times Cited: 61
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics
Vaishali Verma, N. D. Sinha, A. Raja
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Affinity maturation of antibody fragments: A review encompassing the development from random approaches to computational rational optimization
Jiaqi Li, Guangbo Kang, Jiewen Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 247, pp. 125733-125733
Open Access | Times Cited: 23
Challenges and solutions for the downstream purification of therapeutic proteins
Shuo Tang, Jiaoli Tao, Ying Li
Antibody Therapeutics (2023) Vol. 7, Iss. 1, pp. 1-12
Open Access | Times Cited: 18
Structural Modeling of Nanobodies: A Benchmark of State-of-the-Art Artificial Intelligence Programs
Mario S. Valdés‐Tresanco, Mario E. Valdés‐Tresanco, Daiver E. Jiménez-Gutiérrez, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 3991-3991
Open Access | Times Cited: 17
Antibody-Based Immunotherapies as a Tool for Tackling Multidrug-Resistant Bacterial Infections
António M. M. Seixas, Sílvia A. Sousa, Jorge H. Leitão
Vaccines (2022) Vol. 10, Iss. 11, pp. 1789-1789
Open Access | Times Cited: 27
Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases
Renaud Felten, Philippe Mertz, E. Sebbag, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103612-103612
Open Access | Times Cited: 14
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 6
The future of integrated structural biology
Harald Schwalbe, Pauline Audergon, Natalie Haley, et al.
Structure (2024) Vol. 32, Iss. 10, pp. 1563-1580
Open Access | Times Cited: 6
Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities
Jiewen Wang, Guangbo Kang, Huiying Lu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 5
Emerging paradigms and recent progress in targeting ErbB in cancers
Nicolas Stoup, Maxime Liberelle, Nicolas Lebègue, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 552-576
Open Access | Times Cited: 5
Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies
Zelin Feng, Guangbo Kang, Jiewen Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114174-114174
Open Access | Times Cited: 20
Polyspecificity - An emerging trend in the development of clinical antibodies
Sandeep Sherawat, Suraj H. Shinde, Abhay H. Pande
Molecular Immunology (2023) Vol. 155, pp. 175-183
Closed Access | Times Cited: 12
Computer tomography-based assessment of perivascular adipose tissue in patients with abdominal aortic aneurysms
Daniel Ginzburg, Sebastian Nowak, Ulrike Attenberger, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Closed Access | Times Cited: 4
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of de novo humanized and sequence-optimized single domain antibodies: a prospective case study
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Generation of Site‐Specifically Labeled Affinity Reagents via Use of a Self‐Labeling Single Domain Antibody
Stanley Fayn, Swarnali Roy, Chino C. Cabalteja, et al.
Advanced Science (2025)
Open Access
Multivalent nanobody-based sandwich enzyme-linked immunosorbent assay for sensitive detection of porcine reproductive and respiratory syndrome virus
Mingxia Sun, Yue Sun, Yongbo Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128896-128896
Open Access | Times Cited: 9
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality
Monica L. Fernández‐Quintero, Enrico Guarnera, Djordje Müsil, et al.
Protein Science (2024) Vol. 33, Iss. 11
Open Access | Times Cited: 3
Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations
Zixuan Bai, Jiewen Wang, Jiaqi Li, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 21, pp. 601-613
Open Access | Times Cited: 14
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Ziqiang Ding, Shuyang Sun, Xuan Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Fundamental concepts of protein therapeutics and spacing in oncology: an updated comprehensive review
Bahareh Farasati Far, Maryam Safaei, Fatemeh Mokhtari, et al.
Medical Oncology (2023) Vol. 40, Iss. 6
Closed Access | Times Cited: 7
Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments
Karen Manoutcharian, Goar Gevorkian
Fish & Shellfish Immunology (2023) Vol. 138, pp. 108808-108808
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top